Cargando…

Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade

BACKGROUND: Whether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an important concern for anti-IL-6 therapy. We aimed to investigate the effects of IL-6 blockade on long-term immunity to SARS-CoV-2. METHODS: Prospective, lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masiá, Mar, Fernández-González, Marta, García, José Alberto, Padilla, Sergio, García-Abellán, Javier, Botella, Ángela, Mascarell, Paula, Agulló, Vanesa, Gutiérrez, Félix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265168/ https://www.ncbi.nlm.nih.gov/pubmed/35816896 http://dx.doi.org/10.1016/j.ebiom.2022.104153

Ejemplares similares

Preemptive interleukin-6 blockade in patients with COVID-19
por: Guillén, Lucía, et al.
Publicado: (2020)

Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
por: Masiá, Mar, et al.
Publicado: (2020)

SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
por: Masiá, Mar, et al.
Publicado: (2021)

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Pericarditis caused by Mycobacterium africanum: case report
por: Mascarell, Paula, et al.
Publicado: (2022)

Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
por: García-Abellán, Javier, et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study
por: García-Abellán, Javier, et al.
Publicado: (2021)

Late reinfection with a different severe acute respiratory syndrome coronavirus-2 clade in a patient with refractory arterial hypertension: a case report
por: García-Abellán, Javier, et al.
Publicado: (2021)

Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study
por: Masiá, Mar, et al.
Publicado: (2021)

Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy
por: Galdamez, Ronald, et al.
Publicado: (2019)

Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015
por: Masiá, Mar, et al.
Publicado: (2019)

Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19
por: Padilla, Sergio, et al.
Publicado: (2020)

Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study
por: Agulló, Vanesa, et al.
Publicado: (2021)

Contribution of Human Herpesvirus 8 and Herpes Simplex Type 2 to Progression of Carotid Intima-Media Thickness in People Living With HIV
por: Lidón, Fernando, et al.
Publicado: (2019)

Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study
por: Masiá, Mar, et al.
Publicado: (2021)

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
por: Padilla, Authors: Sergio, et al.
Publicado: (2011)

Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter?
por: Fernández-González, Marta, et al.
Publicado: (2021)

Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age
por: Masiá, Mar, et al.
Publicado: (2021)

Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study
por: Masiá, Mar, et al.
Publicado: (2011)

Predictors of Pneumococcal Co-infection for Patients with Pandemic (H1N1) 2009
por: Masiá, Mar, et al.
Publicado: (2011)

Human Infection with Rickettsia sibirica mongolitimonae, Spain, 2007–2011
por: Ramos, José M., et al.
Publicado: (2013)

Dyspnea and pleuritic chest pain during the COVID-19 pandemic
por: Guillén, Lucía, et al.
Publicado: (2021)

Dyspnea and pleuritic chest pain during the COVID-19 pandemic
por: Guillén, Lucía, et al.
Publicado: (2021)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial
por: Masiá, Mar, et al.
Publicado: (2017)

La enseñanza de las enfermedades infecciosas en el grado de Medicina en el marco del espacio europeo de educación superior
por: Gutiérrez, Félix, et al.
Publicado: (2016)

Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test
por: Ramos, José M, et al.
Publicado: (2012)

Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients
por: Masiá, Mar, et al.
Publicado: (2016)

Cancer screening in people living with HIV
por: Masiá, Mar, et al.
Publicado: (2023)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report
por: Conde-Díaz, Cristina, et al.
Publicado: (2017)

Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade
por: Pelosi, Laura, et al.
Publicado: (2015)

Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Antimicrobial Resistance of Coagulase-Positive Staphylococcus Isolates Recovered in a Veterinary University Hospital
por: Pérez-Sancho, Marta, et al.
Publicado: (2020)

Why not treat human cancer with interleukin-1 blockade?
por: Dinarello, Charles A.
Publicado: (2010)

Interleukin-1 Receptor Blockade in Perinatal Brain Injury
por: Rosenzweig, Jason M., et al.
Publicado: (2014)

Rethinking interleukin-6 blockade for treatment of COVID-19
por: Scherger, S., et al.
Publicado: (2020)

Interleukin‐1 blockade treatment decreasing cardiovascular risk
por: Zheng, Zi‐Heng, et al.
Publicado: (2019)

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
por: George, Marc Jonathan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hfitjoj15ubddgqd8c6btsv790